Nationwide Fund Advisors’s ChemoCentryx, Inc. CCXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-13,828
Closed -$103K 2427
2017
Q3
$103K Hold
13,828
﹤0.01% 2889
2017
Q2
$129K Hold
13,828
﹤0.01% 2803
2017
Q1
$101K Sell
13,828
-1,449
-9% -$10.4K ﹤0.01% 2842
2016
Q4
$113K Hold
15,277
﹤0.01% 2837
2016
Q3
$92K Sell
15,277
-80,800
-84% -$382K ﹤0.01% 2919
2016
Q2
$431K Buy
96,077
+77,386
+414% +$290K ﹤0.01% 2232
2016
Q1
$47K Hold
18,691
﹤0.01% 2995
2015
Q4
$151K Hold
18,691
﹤0.01% 2682
2015
Q3
$113K Hold
18,691
﹤0.01% 2845
2015
Q2
$154K Sell
18,691
-1,392
-7% -$11.1K ﹤0.01% 2850
2015
Q1
$152K Sell
20,083
-862
-4% -$6.74K ﹤0.01% 2826
2014
Q4
$143K Hold
20,945
﹤0.01% 2802
2014
Q3
$94K Buy
20,945
+391
+2% +$2.07K ﹤0.01% 3007
2014
Q2
$120K Buy
20,554
+1,665
+9% +$9.35K ﹤0.01% 2974
2014
Q1
$125K Hold
18,889
﹤0.01% 2669
2013
Q4
$109K Sell
18,889
-634
-3% -$3.27K ﹤0.01% 2927
2013
Q3
$109K Buy
19,523
+8,987
+85% +$97.2K ﹤0.01% 2911
2013
Q2
$149K Buy
+10,536
New +$137K ﹤0.01% 2632

Other funds holding CCXI

Nationwide Fund Advisors's CCXI Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of ChemoCentryx, Inc. (CCXI) in Q4 2017, closing a stake of 13,828 shares — an estimated $103K sold.

Nationwide Fund Advisors first reported a position in CCXI in Q2 2013 and held it in 18 quarters. The position peaked at $431K in Q2 2016. 87 funds tracked by Wall St. Rank hold CCXI as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining ChemoCentryx, Inc. position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 13,828 ChemoCentryx, Inc. shares in Q4 2017, an estimated $103K.
  • Nationwide Fund Advisors first reported a position in ChemoCentryx, Inc. in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's ChemoCentryx, Inc. position peaked at $431K in Q2 2016.
  • 87 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.